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Objective: To investigate the extraintestinal manifestations of non-typhoidal Salmonellae (NTS)
infection in immunocompetent infants and children.
Method: The study took place at the University General Hospital at Heraklion, Crete. Over a 10-
year period from 1993—2002 we studied 1087 patients, of whom 443 were children less than 14
years old, with a culture-proven diagnosis of NTS infection. Stool and blood cultures were
routinely obtained in patients presenting with fever and diarrhea. The cases of invasive infection
in otherwise well children, including bacteremia and/or extraintestinal focal infections were
further analyzed.
Results: Invasive cases were less common in children than adults (4.06% vs. 8.7%; relative risk
0.467; 95% confidence intervals (CI) 0.279—0.784; p = 0.0033). Furthermore, invasive cases were
much less common in the otherwise well than in immunocompromised children (3.5% vs. 21.4%;
relative risk 0.163; 95% CI 0.053—0.500; p = 0.0008). The 15 otherwise well children with invasive
NTS infection were aged from 3 weeks to 7.5 years, and nine were aged less than 12 months.
Among them, 11 presented with bacteremia, and four with focal extraintestinal infections (rectal
abscess, deep neck abscess, urinary tract infection, elbow arthritis). Salmonella enterica subsp.
enterica serovars Enteritidis and Virchow were the most common invasive serotypes. All invasive
strains were susceptible to beta-lactams including ampicillin, and to cotrimoxazole. All patients
made a complete recovery with intravenous antibiotics and did not present with relapses or major
infections during long-term follow-up.
Conclusion: Invasive non-typhoidal salmonellosis in immunocompetent children is less frequent
than in both immunocompromised children and in adulthood. However, invasive cases may well* Corresponding author. Tel.: +30 2810 392 012; fax: +30 2810 392 827.
E-mail address: egalanak@med.uoc.gr (E. Galanakis).
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Invasive non-typhoidal salmonellosis in immunocompetent infants and children 37occur in otherwise healthy children, especially during infancy. In these patients, prompt
appropriate treatment leads to favorable outcomes.
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Theusual clinical presentation of non-typhoidal Salmonellae
(NTS) infection is self-limited gastroenteritis, however bac-
teremia and focal extraintestinal infections may occur.
Incidence rates of invasive salmonellosis vary widely and
are higher in individuals at the extremes of life, the immu-
nocompromised, and patients with hemoglobinopathies and
hemolytic anemias.1—5 In contrast to NTS gastroenteritis,
invasive disease has a guarded outcome and prompt anti-
biotic treatment is essential.6—10 In this study we investi-
gated the frequency, presentation and outcome of invasive
NTS infections in otherwise well children being treated at a
referral general hospital, in a well-defined geographical
area, and over a long period.
Population and methods
Study setting and design
The University General Hospital at Heraklion, Crete is the
main tertiary care setting in the island covering a population
of 611 000, of whom 132 000 are children aged 0—14 years
(2001 census data). The mean annual admission rate during
the study period was 45 104 patients, of whom 4574 were
children less than 14 years old. The study included all
patients hospitalized from January 1993 to December
2002with a culture positive for NTS. Stool and blood cultures
were routinely obtained in patients presenting with fever
and diarrhea. The cases of invasive infection in otherwise
well children, including bacteremia and/or extraintestinal
focal infections were further analyzed.
Bacteriology
Blood cultures were performed using the BacT/Alert System
(Organon Teknika Corporation, North Carolina, USA). Stool
specimens were cultured on routine bacteriologic media
employed for enteric pathogens according to usual protocols
(all media products of BioMe´rieux, Marcy l’Etoile, France).11
The isolated organisms were identified biochemically
according to standard methods, the API system (BioMe´r-
ieux), and commercial antisera (Bio-Rad, Marnes-la-
Coquette, France). Susceptibility to antimicrobial agents
was determined by the disk diffusion method recommended
by the Clinical and Laboratory Standards Institute.12
Statistics
Relative risks with 95% confidence intervals (CI) were calcu-
lated to compare incidence differences between groups.
The Chi-square test was used to estimate the statistical
significance of differences, and values of p < 0.05 were
considered to be significant.Results
NTS infection
A culture-proven NTS infection was documented in 1087
patients, 443 (41%) of whom were children under 14 years
of age, and 644 (59%) adolescents and adults. Eighteen
children (4.1%) and 56 adolescents and adults (8.7%) pre-
sented with bacteremia and/or focal infection. The relative
risk for invasive disease among children was 0.467 as com-
pared to the adult patients (95%CI 0.279—0.784;p = 0.0033).
Among the 443 children, 14 (3.2%) were immunocompro-
mised and 429 (96.8%) were otherwise well. Three children
from the first group and 15 from the second presented with
invasive NTS infection (21.4% and 3.5%, respectively).
Otherwise well children had a significantly lower risk for
invasive NTS infection than their immunocompromised
peers (relative risk 0.163, 95% CI 0.053—0.500; p = 0.0008).
Of the 429 children with a culture positive for NTS, four
(0.9%) were aged less than 4 weeks, presenting with gastro-
enteritis (3) and urinary tract infection (1). NTS were the
most common bacterial isolates in childhood gastroenteritis
in the area of the study, accounting for 36.5% of all stool
bacterial isolates during the study period.
Invasive NTS infection
Among the 15 children with invasive NTS infection seven
(47%) were girls and eight (53%) were boys. The median age
was 0.9 years (range 24 days—7.5 years) and nine (60%)
were infants aged less than 1 year. Medical history did not
reveal underlying predisposing conditions in any of the
children. A history of prematurity was recalled in a single
child. Thirteen children (87%) presented with fever >39 8C,
11 (73%) with gastrointestinal symptoms, two (13%) with a
maculopapular rash, and one (7%) with febrile seizures.
Bacteremia occurred in 11 (73%) and focal infections were
documented in four (27%) patients. A 5-month-old boy
presented with vomiting, bloody diarrhea, and a rectal
abscess without fever; a 4-year-old girl presented with
fever, left-side torticollis, and a deep neck abscess; a
24-day-old infant presented with fever and failure to thrive
and grew Salmonella spp in urine; a 5-year-old boy pre-
sented with left elbow swelling, a history of gastroenteritis
a month ago, and grew Salmonella enterica subsp. enterica
ser. Virchow in synovial fluid.
Serotypes and susceptibility
The frequency of serotypes in stool and blood/focal cul-
tures is shown in Table 1. All cases were community-
acquired. S. enterica subsp. enterica serovars Typhi and
Paratyphi were not isolated from infants or children. By
contrast, S. enterica subsp. enterica ser. Typhi was isolated
38 E. Galanakis et al.from three adults and S. enterica subsp. enterica ser.
Paratyphi B from four adults. The overall resistance rates
of NTS strains were 26.3% to ampicillin, 29.9% to tetracy-
cline, 6.8% to chloramphenicol, and 3.6% to cotrimoxazole.
All isolates were susceptible to quinolones and third gen-
eration cephalosporins. All invasive strains were sensitive
to beta-lactams including ampicillin, and to cotrimoxazole.
Laboratory findings
The mean white blood cell count in the 15 infants and
children with invasive NTS infection was 10.4  109/L (range
7.8—15.7), the mean neutrophil count 4.9  109/L (range
2.2—9.1), and the mean erythrocyte sedimentation rate was
59.4 (range 30—92) mm/h. Only four (27%) children had
leukocytosis (white cell count >12.0  109/L) and none
had leukopenia. All bacteremic patients had a sterile repeat
blood culture. Serum immunoglobulin determination and
hemoglobin electrophoresis were performed in nine (60%)
children. A sickle-cell trait was confirmed in a single child.
Management and outcome
All children received intravenous antibiotics, mostly a third
generation cephalosporin, for 7—30 days. All had an excellent
outcome and did not present with relapses or any other
infections during the follow-up period.
Discussion
In recent studies NTS were found to be the most common
bacterial enteropathogens in children in Greece13—15 and
this was confirmed by our findings. In a recent study con-
ducted by our team, it was found that S. enterica subsp.
enterica were the most commonly isolated bacterial enter-
opathogens accounting for up to 6% of the total diarrheal
patients in Crete, and being more frequently detectedTable 1 Non-typhoidal Salmonellae serovars isolated in 429
otherwise well children (simultaneous isolation in stools and
blood/focal culture is shown in parentheses)
Serovar Stool Blood Focal Total
Enteritidis 335 6 0 335 (6)
Typhimurium 61 1 0 61 (1)
Virchow 3 4 1 (synovial fluid) 7 (1)
Newport 6 1 0 6 (1)
Glostrup 3 0 0 3
Heidelberg 2 0 0 2
Infantis 2 0 0 2
Kottbus 2 0 0 2
Agona 1 1 0 1 (1)
Blockley 1 0 0 1
Braenderup 1 0 0 1
Bredeney 1 0 0 1
Hadar 1 0 0 1
Ramsey 1 0 0 1
Salmonella spp 4 0 1 (urine) 5
Total (patients) 424 13 2 429 (10)in patients over 15 years of age.14 Among children, salmo-
nellosis was diagnosed more frequently in those aged
between 5 and 9 years.14 In the present study, invasive
disease occurred in 3.5% and 21.4% of immunocompetent
and immunocompromised children with NTS infection,
respectively. Incidence values varying from 2% to 47% have
been reported.16—18 Neonates and infants less than 3months
of age with NTS gastroenteritis are widely considered to
be more prone to bacteremia and focal infection. Our find-
ings suggest that this susceptibility extends throughout
infancy, as most of our patients with invasive infection were
infants less than 1 year old, although there was only one
infant of less than 3 months. First line laboratory investiga-
tion in children with invasive NTS infection was commonly
non-specific. The findings in children with NTS bacteremia
are not extremely helpful as they are generally similar
to those in uncomplicated gastroenteritis.10,19,20
Salmonellae are particularly capable of causing focal
suppurative infections of almost any organ.21—25 The urinary
tract infection in our patient was considered to be hema-
togenous as the neonate had no diarrhea or NTS isolation
from stool. The infant with bacteremia and rectal abscess
was afebrile. We are not aware of any detailed description
of a rectal abscess due to NTS infection. Deep neck
abscesses are extremely rare, although the skeletal system
is a common site of focal infection, mainly in individuals
with pre-existing skeletal abnormalities, immune disorders,
or sickle cell disease.
Several studies have suggested particular virulence and
invasiveness of certain NTS serovars including S. enterica
subsp. enterica serovars Enteritidis and Typhimurium.10,26—
28 The invasiveness of S. enterica subsp. enterica ser.
Virchow has increased especially among children, although
the strain has not been shown to harbor a virulence plas-
mid.5,23,27 Interestingly, S. enterica subsp. enterica ser.
Choleraesuis, a well-recognized invasive serovar, was not
isolated from any adult or child, including the immunocom-
promised patients, and no S. enterica subsp. enterica ser-
ovars Typhi or Paratyphi were isolated from children.
Antimicrobial resistance of NTS has been increasing
through the 1990s and is a major problem in several coun-
tries.28 NTS isolates from stools demonstrated broad anti-
biotic resistance in this study, similar to that previously
reported,14 however all invasive isolates were sensitive to
cotrimoxazole and all beta-lactams. All our patients had a
favorable outcome, however persistent bacteremia or
relapse despite adequate antibiotic administration has been
reported.1,5
In conclusion, NTS invasive infection is much less com-
mon in otherwise well children as compared both to their
immunocompromised peers and to adults. However, inva-
sive infection may well occur among otherwise well infants
and children with gastroenteritis, requiring hospitalization.
Infants aged less than 12 months are more susceptible than
older children to invasive infection. In our setting, S. enter-
ica subsp. enterica serovars Enteritidis and Virchow but not
Typhimurium strains were associated with high invasive-
ness. An immunological work-up does not seem necessary
for otherwise healthy children with NTS invasive infection
and the outcome is favorable with appropriate antibiotic
treatment.
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